Baxter International (BAX) Cash from Financing Activities (2009 - 2026)
Baxter International (BAX) reported Cash from Financing Activities of -$11.0 million for Q1 2026, up 99.66% year-over-year from -$5.5 million in Q1 2025, and up 92.52% quarter-over-quarter from -$147.0 million in Q4 2025.
Baxter International (BAX) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Cash from Financing Activities data on file, last reported at -$11.0 million in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$11.0 million, up 99.66% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.0 billion (up 75.98% YoY), and the FY2025 annual result was -$4.2 billion, down 290.01% from the prior year.
- Cash from Financing Activities advanced to -$11.0 million in Q1 2026 per BAX's latest filing, from -$147.0 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $141.0 million in Q4 2024 and troughed at -$3.2 billion in Q1 2025.
- A 5-year average of -$602.1 million and a median of -$147.0 million in 2025 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities tumbled 2366.39% in 2023, then surged 104.8% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at -$119.0 million in 2022, then plunged by 2366.39% to -$2.9 billion in 2023, then surged by 104.8% to $141.0 million in 2024, then tumbled by 204.26% to -$147.0 million in 2025, then surged by 92.52% to -$11.0 million in 2026.
- Business Quant data shows BAX's Cash from Financing Activities at -$11.0 million in Q1 2026, -$147.0 million in Q4 2025, and -$81.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | -230.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.00 Mn |
| Mar 31, 2026 | -11.00 Mn |
| Dec 31, 2025 | -147.00 Mn |
| Dec 31, 2025 | -147.00 Mn |
| Sep 30, 2025 | -81.00 Mn |
| Sep 30, 2025 | -81.00 Mn |
| Jun 30, 2025 | -762.00 Mn |
| Jun 30, 2025 | -762.00 Mn |
| Mar 31, 2025 | -3.23 Bn |
| Mar 31, 2025 | -3.23 Bn |
| Dec 31, 2024 | 141.00 Mn |
| Dec 31, 2024 | 141.00 Mn |
| Sep 30, 2024 | -146.00 Mn |
| Sep 30, 2024 | -146.00 Mn |
| Jun 30, 2024 | -936.00 Mn |
| Jun 30, 2024 | -936.00 Mn |
| Mar 31, 2024 | -140.00 Mn |
| Mar 31, 2024 | -140.00 Mn |
| Dec 31, 2023 | -2.94 Bn |
| Dec 31, 2023 | -2.94 Bn |